GreenLight Biosciences Holdings PBC (GreenLight Biosciences Holdings PBC) Total Assets : $113.69 Mil (As of Mar. 2023)

View and export this data going back to 2022. Start your Free Trial

What is GreenLight Biosciences Holdings PBC Total Assets?

GreenLight Biosciences Holdings PBC's Total Assets for the quarter that ended in Mar. 2023 was $113.69 Mil.

During the past 12 months, GreenLight Biosciences Holdings PBC's average Total Assets Growth Rate was 107.50% per year. During the past 3 years, the average Total Assets Growth Rate was 157.90% per year.

During the past 4 years, GreenLight Biosciences Holdings PBC's highest 3-Year average Total Assets Growth Rate was 157.90%. The lowest was 157.90%. And the median was 157.90%.

Total Assets is connected with ROA %. GreenLight Biosciences Holdings PBC's annualized ROA % for the quarter that ended in Mar. 2023 was -86.83%. Total Assets is also linked to Revenue through Asset Turnover. GreenLight Biosciences Holdings PBC's Asset Turnover for the quarter that ended in Mar. 2023 was 0.03.

GreenLight Biosciences Holdings PBC Total Assets Historical Data

The historical data trend for GreenLight Biosciences Holdings PBC's Total Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

GreenLight Biosciences Holdings PBC Total Assets Chart

GreenLight Biosciences Holdings PBC Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Total Assets

30.61

113.83

63.06

148.60

GreenLight Biosciences Holdings PBC Quarterly Data
	Dec19	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23
Total Assets	Get a 7-Day Free Trial							122.43	98.81	151.42	148.60	113.69

GreenLight Biosciences Holdings PBC Total Assets Calculation

Total Assets are all the assets a company owns.

From the capital sources of the assets, some of the assets are funded through shareholder's paid in capital and retained earnings of the business. Others are funded through borrowed money.

GreenLight Biosciences Holdings PBC's Total Assets for the fiscal year that ended in Dec. 2022 is calculated as

Total Assets	=	Total Equity (A: Dec. 2022 )	+	Total Liabilities (A: Dec. 2022 )
	=	48.062	+	100.536
	=	148.60

GreenLight Biosciences Holdings PBC's Total Assets for the quarter that ended in Mar. 2023 is calculated as

Total Assets	=	Total Equity (Q: Mar. 2023 )	+	Total Liabilities (Q: Mar. 2023 )
	=	21.936	+	91.753
	=	113.69

GreenLight Biosciences Holdings PBC (NAS:GRNA) Total Assets Explanation

Total Assets is connected with ROA %.

GreenLight Biosciences Holdings PBC's annualized ROA % for the quarter that ended in Mar. 2023 is

ROA %	=	Net Income (Q: Mar. 2023 )	/	( (Total Assets (Q: Dec. 2022 )	+	Total Assets (Q: Mar. 2023 ))	/ count )
	=	-113.876	/	( (148.598	+	113.689)	/ 2 )
	=	-113.876	/	131.1435
	=	-86.83 %

Note: The Net Income data used here is four times the quarterly (Mar. 2023) data.

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Total Assets is linked to total revenue through Asset Turnover.

GreenLight Biosciences Holdings PBC's Asset Turnover for the quarter that ended in Mar. 2023 is

	Asset Turnover
=	Revenue (Q: Mar. 2023 )	/	( (Total Assets (Q: Dec. 2022 )	+	Total Assets (Q: Mar. 2023 ))	/ count )
=	3.82	/	( (148.598	+	113.689)	/ 2 )
=	3.82	/	131.1435
=	0.03

Therefore, if a company grows its Total Assets faster than its Revenue, the Asset Turnover will decline. This might be a warning sign for the business.

GreenLight Biosciences Holdings PBC Total Assets Related Terms

Thank you for viewing the detailed overview of GreenLight Biosciences Holdings PBC's Total Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

GreenLight Biosciences Holdings PBC (GreenLight Biosciences Holdings PBC) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GreenLight Biosciences Holdings PBC (NAS:GRNA) » Definitions » Total Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

29 Hartwell Avenue, Lexington, MA, USA, 02421

Website

https://www.greenlightbiosciences.com

GreenLight Biosciences Holdings PBC is a pre-commercial stage synthetic biology company with a proprietary cell-free ribonucleic acid production platform for the discovery, development, and commercialization of high-performing products to promote healthier plants, foods, and people. The company is developing RNA products for plant and life science applications to advance crop management, plant protection, animal health, vaccine development, and pandemic preparation.

Executives

Deval L Patrick	other: See Remarks	BAIN CAPITAL, LLC, 200 CLARENDON STREET, BOSTON MA 02116
Dennis A. Clarke	other: Member of 13D group owning 10%	6 FERNWAY TERRACE, WINCHESTER MA 01890
Cummings Foundation, Inc.	other: Member of 13D group owning 10%	200 WEST CUMMINGS PARK, WOBURN MA 01801
Eric Senior Anderson	other: Member of 13D group owning 10%	25 N HILL ROAD, WESTOVER MA 01886
Mls Capital Fund Ii Lp	other: See remarks	C/O MLSC II (GP) (LABUAN) LLP, ONE MARKET ST SUITE 3525, SAN FRANCISCO CA 94105
Chelt Trading Ltd	other: Member of 13D Group	C/O FOX HORAN & CAMERINI LLP, 885 3RD AVENUE, 17TH FLOOR, NEW YORK NY 10022
Highview Trust	other: Member of 13D Group	C/O FOX HORAN & CAMERINI LLP, 885 THIRD AVENUE, 17TH FLOOR, NEW YORK NY 10022
Montealegre Lacayo Jaime Javier	other: Member of 13D Group	APARTADO 15-1250, ESCAZU G2
Furneaux Capital Holdco, Llc	other: Member of 13D group	1 MARINA PARK DRIVE, BOSTON MA 02210
Lewis & Clark Plant Sciences Fund I, Lp	other: Member of 13D group	120 S. CENTRAL AVENUE, SUITE 1000, ST. LOUIS MO 63105
Lewis & Clark Ventures I, Lp	other: Member of 13D group	120 S. CENTRAL AVENUE, SUITE 1000, ST. LOUIS MO 63105
Matthew Allen Walker	director, 10 percent owner	C/O GREENLIGHT BIOSCIENCES HOLDINGS, PBC, 200 BOSTON AVENUE, SUITE 3100, MEDFORD MA 02155
Martha Schlicher	director	C/O GREENLIGHT BIOSCIENCES HOLDINGS, PBC, 200 BOSTON AVENUE, SUITE 3100, MEDFORD MA 02155
Marta Ortega-valle	other: Member of 10% owner group	C/O GREENLIGHT BIOSCIENCES HOLDINGS, PBC, 200 BOSTON AVENUE, SUITE 3100, MEDFORD MA 02155
Builders Vision, Llc	10 percent owner	110 NW 2ND STREET SUITE 300, BENTONVILLE AR 72712